Key takeaways
- Both are percentage-oriented models, so both scale their fee with your success. They differ in how much and in what else they carry.
- Neither publishes complete pricing, so any comparison depends on operator-reported terms and written proposals.
- OpenLoop's proposal terms deposit patient payments into OpenLoop's merchant account and pay the brand a fee weekly.
- Bask has the stronger developer surface and holds SOC 2 Type II. OpenLoop has the deeper clinical operation.
- If flat-fee economics and brand-owned payments matter more than either, a third option is relevant.
What each one is actually selling
Bask Health sells a broad white-label platform with a comparatively mature developer surface: SDK access, integrations and configurability aimed at teams who intend to build on top of the platform rather than only operate within it. It holds SOC 2 Type II.
OpenLoop sells clinical operations at scale. Its proposal materials describe provider recruiting, licensing, credentialing, malpractice coverage, a 24/7 patient support desk, and a supply chain where OpenLoop carries medication and lab costs directly.
These are genuinely different products underneath a similar description, and the right choice between them depends less on features than on how much of the operation you want to own.
The economics
Neither publishes complete pricing, which is itself a comparison point. What is available comes from written proposals and operator reports.
OpenLoop's Summary of Proposed Services dated 05.28.26 sets a $9,000 implementation fee and a $1,500 monthly technology and systems access fee on a 12-month initial term, and then pays the brand a Membership Services Fee out of patient payments OpenLoop collects. On its semaglutide schedule the patient pays $249 and the brand receives $140 in month one, falling to $124 from month five.
Bask does not publish a percentage. Operators report a blended effective take in the high teens to low twenties once processing is included, on top of a platform fee.
Who receives the money
This is the sharpest structural difference and the one least visible in a demo.
Under OpenLoop's proposal terms, the patient enters a card on the brand's interface but the charge is deposited to OpenLoop's merchant account, and OpenLoop remits the brand's fee every Wednesday for the week ending Tuesday, based on its own count of net active patients. The brand is paid a fee out of revenue it did not receive.
Bask also operates as merchant of record in its standard configuration. In both cases the stored card tokens sit with the platform, which is what determines the cost of leaving later.
Speed and multi-brand
Bask implementations commonly run 30 to 40 days. OpenLoop implementations commonly run 30 to 60 days depending on clinical configuration and contracting.
On multi-brand, OpenLoop's proposal states that added business lines require an addendum to the MSA and a separate implementation fee. A portfolio operator therefore pays implementation again per line.
| Bask Health | OpenLoop | |
|---|---|---|
| Pricing model | Platform fee plus percentage | Fees plus a share of collections |
| Published pricing | No | No |
| Merchant of record | Bask | OpenLoop |
| Contract term | Not published | 12-month initial term |
| Launch timeline | 30 to 40 days | 30 to 60 days |
| SOC 2 Type II | Yes | Not published |
| Developer surface | Strong | Moderate |
| Clinical depth | Strong | Strong |
| Carries medication cost | No | Yes |
Which of the two to choose
Choose Bask if you have an engineering team that will build meaningfully on the platform, or if SOC 2 Type II attestation is a procurement gate for your buyer. The developer surface is the real differentiator and it is worth paying for when you will use it.
Choose OpenLoop if you want the clinical operation genuinely outsourced, including the working capital. They fund medication and lab costs, absorb merchant reserves and chargebacks, and run 24/7 patient support. Roughly half of patient revenue is the honest price of that transfer, and for an operator who does not want to carry inventory risk it can be a rational trade.
The third option, stated plainly
This is published by PharmaBro, so treat the following as an interested party's disclosure rather than a neutral verdict. The reason it belongs on the page is that it answers a question neither of the above does.
If what you want is flat published pricing, payments settling into a Stripe account your brand owns, no revenue share, no contract term and unlimited brands on one account, neither Bask nor OpenLoop is structured that way. PharmaBro publishes $15,000 to $50,000 setup and $1,500 to $5,000 a month, with a transaction fee falling from 3% to 1.5%, and launches in 5 days.
What PharmaBro does not have: SOC 2 Type II attestation, which Bask does hold. If that is a hard requirement, Bask is the better answer and we would rather say so here.
A different structure, not a cheaper version of the same one
The distinction is not price, it is direction. Under a percentage or a collections model, the platform receives your patients' money and pays you a share. Under a flat fee with brand-owned payments, you receive the money and pay the platform a fee.
Published pricing. Your own Stripe. Zero revenue share. Live in 5 days. Unlimited brands, no term, full export in 24 hours.
Conclusion
Bask and OpenLoop are both credible and they are solving different problems: one is a platform to build on, the other is an operation to outsource to.
What they share is the structure that decides most of a telehealth brand's economics: a fee indexed to your success, and a merchant account that is not yours. Whether that is acceptable depends on how much of the operation you want to own, and it is worth deciding deliberately rather than discovering later.
Frequently asked questions
Which is cheaper, Bask or OpenLoop?
Neither publishes complete pricing, so an honest answer requires written proposals from both. OpenLoop's proposal terms are documented in its Summary of Proposed Services; Bask's percentage is operator-reported. Ask both for the percentage, the base it is calculated on, and the merchant-of-record position in writing.
Do Bask or OpenLoop let me use my own Stripe account?
In their standard configurations, no. Both operate as merchant of record, which means patient payments settle into their accounts and the stored card tokens sit with them. Ask specifically about token portability before signing, because it determines what leaving costs.
Which launches faster?
They are comparable. Bask implementations commonly run 30 to 40 days and OpenLoop 30 to 60 depending on clinical configuration and contracting steps.
Is there a flat-fee alternative to both?
Yes, and this page is published by one of them, so weigh that accordingly. PharmaBro, Cuvo and Rimo all operate flat-fee models. They differ on merchant of record, multi-brand terms and contract length, which are the questions worth asking each of them.
References
- 1.OpenLoop, Summary of Proposed Services, 05.28.26, Schedules A to E
- 2.Bask Health platform and security documentation
- 3.Stripe published processing rates
Every figure above is sourced and dated. If you represent one of the platforms named here and something is out of date or wrong, write to support@pharmabro.co and we will correct it and note the change on the page.
Anmol SethiFounder
Ran direct-to-consumer telehealth brands and paid a revenue share on every dollar they earned. Built PharmaBro as the infrastructure he wanted to buy.